Parallel Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Parallel Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-73	Closed	-$1K	–	2973
2020 Q4	$1K	Sell	73 -48	-40%	-$875	﹤0.01%	2541
2020 Q3	$2K	Buy	121 +109	+908%	+$1.83K	﹤0.01%	2386
2020 Q2	$0	Buy	+12	New	+$171	﹤0.01%	2819

Parallel Advisors's CBMG Position: Q1 2021 in Review

Parallel Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 73 shares — an estimated $1K sold.

Parallel Advisors first reported a position in CBMG in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Parallel Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Parallel Advisors sold 73 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1K.
Parallel Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q2 2020 and held it in 3 quarters.
Parallel Advisors's Cellular Biomedicine Group, Inc. position peaked at $2K in Q3 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Parallel Advisors's 13F filing for Q1 2021, filed 23 Apr 2021.